Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 2007

View Archived Issues

Recent Solvay patent discloses novel therapeutic agents for gastrointestinal disorders

New therapeutic options for cardiovascular disorders claimed in recent patent literature

Novel treatment option for sepsis reported in recent Dompe patent

Recent GTx patent reports novel therapeutic agents for osteoporosis

Shire and Noven to develop new ADHD patch

Advanced Cell Technology advances retinal pigment epithelial program

New data on PBI-1393's antiinflammatory mechanism of action

Positive phase II results from Lymphoseek for cancer and melanoma

VGX International receives exclusive license of VGX-100 for gastric cancer

Oncolys and Tacere to jointly develop TT-033 for hepatitis C

LAB International licenses Fentanyl Taifun to Janssen Pharmaceutica

Positive results in pivotal phase III trial of cethromycin for CAP

Paquinimod shows steroid-sparing effects in animal models of lupus

Endometrin approved for use in assisted reproductive technology treatment

Novel selective p38 MAP kinase inhibitor described by BMS

Strong antiinflammatory activity of novel anti-C5aR antibody in animal models of arthritis

Positive topline findings from Tovaxin MS extension study

Encouraging data for GRN-163L in ongoing CLL study

New sites added to phase II trial of low-dose interferon alpha lozenges

Preclinical efficacy of a novel SARS virus vaccine strategy

European CHMP recommends approval of Sandoz's biosimilar epoetin alfa

PegIntron and Rebetol approved in E.U. for HCV patients coinfected with HIV

Symbicort pMDI available in U.S.

Supprelin LA launched for central precocious puberty

Ancaron Injection launched in Japan for arrhythmia

Satraplatin filed in E.U.

New indication approved for Tambocor in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...